A compound which stimulates anabolism and inhibits catabolism. Anabolic agents stimulate the development of muscle mass, strength, and power.
| Member | Definition | Class |
|---|
| 1-testosterone | An anabolic steroid that differs from testosterone by having a 1,2-double bond instead of a 4,5-double bond in its A ring. A potent androgen with anabolic properties, it was legally sold as a prohormone in the U.S.A. until 2005, when it was reclassified as a Schedule III drug. | Delta(1)-dihydrotestosterone |
| dromostanolone | | metholone |
| ethylestrenol | A 17beta-hydroxy steroid that is estrane containing a double bond between positions 4 and 5 and substituted by an ethyl group and a hydroxy group at the 17alpha and 17beta positions, respectively. It is an anabolic steroid that has little androgenic effect and only slight progestational activity. It has been used to promote growth in boys with delayed bone growth. | ethylestrenol |
| fluoxymesterone | | fluoxymesterone |
| methyltestosterone | A 17beta-hydroxy steroid that is testosterone bearing a methyl group at the 17alpha position. | methyltestosterone |
| mibolerone | An androgen that is nalandrone carrying two methyl substituents at positions 7alpha and 17. | mibolerone |
| myrcene | A monoterpene that is octa-1,6-diene bearing methylene and methyl substituents at positions 3 and 7 respectively. | beta-myrcene |
| nandrolone phenpropionate | | nandrolone phenpropionate |
| oxandrolone | | oxandrolone |
| stanozolol | An organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine. Like oxymetholone, it is a synthetic anabolic steroid. It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders. It has also been widely abused by professional athletes. | stanozolol |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| acetylcholinesterase | Homo sapiens (human) | Potency | 0.3467 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| AR protein | Homo sapiens (human) | Potency | 4.5569 | 12 | 57 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 76.9588 | 1 | 1 |
| Ataxin-2 | Homo sapiens (human) | Potency | 21.6899 | 1 | 1 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 21.6899 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 23.7101 | 1 | 1 |
| caspase-3 | Homo sapiens (human) | Potency | 23.7101 | 1 | 1 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 18.1951 | 2 | 5 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 7.9433 | 1 | 1 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 79.4328 | 1 | 1 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 14.1161 | 1 | 2 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 9.6632 | 1 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 3.2834 | 1 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 8.3745 | 1 | 4 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 18.2896 | 11 | 39 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 4.6234 | 3 | 15 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 34.2014 | 8 | 32 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 1.9953 | 1 | 1 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 27.0164 | 3 | 7 |
| G | Vesicular stomatitis virus | Potency | 14.1161 | 1 | 2 |
| GALC protein | Homo sapiens (human) | Potency | 0.7079 | 1 | 1 |
| geminin | Homo sapiens (human) | Potency | 10.1973 | 2 | 3 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 17.8273 | 2 | 14 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 14.9872 | 1 | 2 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 6.1737 | 4 | 13 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 47.1089 | 1 | 3 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 31.4601 | 2 | 4 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 72.5694 | 2 | 5 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 14.1161 | 1 | 2 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 26.8325 | 2 | 2 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 14.1161 | 1 | 4 |
| Interferon beta | Homo sapiens (human) | Potency | 20.5087 | 2 | 3 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 31.6228 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 38.8034 | 3 | 12 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 53.3506 | 1 | 3 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 23.3174 | 1 | 2 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 14.1254 | 1 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 37.3974 | 2 | 5 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 9.0743 | 1 | 1 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 24.2334 | 5 | 6 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 29.1782 | 5 | 8 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 12.5893 | 1 | 1 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 33.3583 | 3 | 7 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 36.2530 | 1 | 2 |
| progesterone receptor | Homo sapiens (human) | Potency | 10.6039 | 3 | 17 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 24.3845 | 2 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 34.5971 | 3 | 14 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 27.0034 | 2 | 8 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 26.9369 | 2 | 2 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 26.9369 | 2 | 2 |
| Smad3 | Homo sapiens (human) | Potency | 3.9811 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 35.4813 | 1 | 1 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| TDP1 protein | Homo sapiens (human) | Potency | 16.1210 | 2 | 9 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 70.7946 | 1 | 1 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 21.5481 | 2 | 9 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 0.8913 | 1 | 1 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 27.2446 | 4 | 4 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 1.7560 | 1 | 2 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 12.5893 | 1 | 1 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 12.5893 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 6.3096 | 1 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 29.9834 | 2 | 8 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 15.7375 | 3 | 5 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 47.1089 | 1 | 3 |